Nevirapine Tablet, Extended Release
Product Images NDC 0378-4890

4 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nevirapine (NDC 0378-4890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nevirapine Extended-release Tablets, Usp 100 mg Bottle Label (Image 01)

Nevirapine Extended-release Tablets, Usp 100 mg Bottle Label (Image 01)
Nevirapine Extended-Release Tablets, USP 100 mg by Mylan Pharmaceuticals Inc. The label shows a bottle containing 90 extended-release tablets for oral use. It includes dosage details, storage instructions (20° to 25°C), and a caution that tablets must be swallowed whole without chewing or crushing. The packaging states it is Rx only and manufactured in India.*
FDA Label Image

Mosteller Formula (Image 02)

Mosteller Formula (Image 02)
A formula labeled as the Mosteller Formula for calculating Body Surface Area (BSA) in square meters (m²). The formula shows the square root of the product of Height (cm) and Weight (kg) divided by 3600.*
FDA Label Image

Nevirapine Structural Formula (Image 03)

Nevirapine Structural Formula (Image 03)
Chemical structure of nevirapine, depicting its bicyclic ring system with nitrogen atoms and attached functional groups, including a cyclopropyl group and methyl substituent.*
FDA Label Image

Nevirapine Extended-release Tablets, Usp 400 mg Bottle Label (Image 04)

Nevirapine Extended-release Tablets, Usp 400 mg Bottle Label (Image 04)
Nevirapine Extended-Release Tablets, USP 400 mg by Mylan Pharmaceuticals Inc. This label shows a 30-tablet bottle with oral extended-release nevirapine tablets. The label includes dosing instructions, storage conditions, a barcode, and packaging details, indicating it is a prescription drug manufactured in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.